ARCHIVES

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Realities Of The 1989 Budget: Number Of grants Cut By 250, Only 255 Of Approved Will By Funded

October 7, 1988

Cancer Research Institute Goes To Wall Street

January 17, 1986

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980